IDS Spotlights Next-Generation Immunoanalyzer at AACC 2019

Immunodiagnostic Systems {(IDS) Boldon, Tyne and Wear, United Kingdom} spotlighted its next-generation immunoanalyzer, the IDS-i10, at the AACC annual meeting and exhibition, which is the world’s largest scientific conference and tradeshow in the laboratory medicine field. This year marked the 71st edition of the scientific meeting and clinical lab expo, held from August 4-8, at the Anaheim Convention Center, in Anaheim, California, USA.

AACC provides a platform to connect with the world’s thought leaders in breaking laboratory medicine operating in fields including: clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine and lab management. As always, this year’s edition was full of technological advances as over 200 new product introductions were unveiled and demonstrated. Additionally, research developments and changes in the laboratory medicine field were discussed, in a variety of clinical areas, through an educational experience, which could be tailored by selecting from a range of scientific sessions.

IDS, a specialist in vitro diagnostic solution provider to the clinical laboratory market, develops, manufactures and markets innovative immunoassays and automated immunoanalyzer technologies to provide improved diagnostic outcomes for patients. At AACC 2019, IDS showcased its next generation immunoanalyzer, the IDS-i10, with faster testing capability and the capacity to connect to laboratory track systems, which can help medical professionals perform automated immunoassays more efficiently than ever. The chemiluminescence-based technology platform is entirely automated and offers continuous loading, as well as random access analysis.